Viewing Study NCT00261612


Ignite Creation Date: 2025-12-26 @ 10:18 PM
Ignite Modification Date: 2025-12-31 @ 2:15 PM
Study NCT ID: NCT00261612
Status: UNKNOWN
Last Update Posted: 2006-10-18
First Post: 2005-12-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma
Sponsor: Medical University of Vienna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module